X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11651) 11651
Newspaper Article (166) 166
Magazine Article (54) 54
Book Chapter (3) 3
Dissertation (2) 2
Publication (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
syngeneic grafts (11710) 11710
transplantation (6203) 6203
allografts (5339) 5339
humans (4498) 4498
liver transplantation (4093) 4093
transplants & implants (3756) 3756
liver (3632) 3632
male (3595) 3595
animals (3242) 3242
female (2896) 2896
medicine (2678) 2678
patients (2665) 2665
kidneys (2643) 2643
surgery (2444) 2444
rodents (2406) 2406
multidisciplinary sciences (2356) 2356
kidney transplantation (2330) 2330
science (2293) 2293
research article (2176) 2176
mice (2114) 2114
liver diseases (1900) 1900
middle aged (1761) 1761
stem cells (1697) 1697
bone marrow (1630) 1630
survival (1595) 1595
analysis (1589) 1589
adult (1554) 1554
gene expression (1475) 1475
bone marrow transplantation (1447) 1447
proteins (1443) 1443
inflammation (1439) 1439
mortality (1390) 1390
risk factors (1371) 1371
heart (1213) 1213
animal models (1201) 1201
health aspects (1182) 1182
heart transplantation (1170) 1170
immunology (1169) 1169
gastroenterology & hepatology (1146) 1146
lung transplantation (1146) 1146
medical research (1142) 1142
apoptosis (1125) 1125
studies (1125) 1125
biology (1104) 1104
fibrosis (1071) 1071
rats (1070) 1070
research (1056) 1056
diabetes mellitus (1043) 1043
diabetes (1041) 1041
xenografts (1035) 1035
cancer (1021) 1021
ischemia (1020) 1020
graft rejection (1012) 1012
disease (1000) 1000
cell biology (930) 930
stem cell transplantation (903) 903
aged (895) 895
heart diseases (890) 890
oncology (888) 888
kidney diseases (885) 885
expression (882) 882
cirrhosis (866) 866
cytokines (860) 860
hepatitis (840) 840
pediatrics (835) 835
transplantation of organs, tissues, etc (825) 825
care and treatment (818) 818
metabolism (806) 806
therapy (805) 805
infections (802) 802
medicine and health sciences (779) 779
medicine, research & experimental (776) 776
tumors (761) 761
biology and life sciences (752) 752
nephrology (741) 741
retrospective studies (734) 734
kinases (732) 732
lymphocytes t (725) 725
biopsy (714) 714
blood (711) 711
mesenchyme (700) 700
children (699) 699
diagnosis (697) 697
lymphocytes (693) 693
immunosuppression (687) 687
hospitals (685) 685
physiology (681) 681
treatment outcome (665) 665
prognosis (662) 662
biochemistry (659) 659
pancreas (655) 655
hypertension (642) 642
complications (635) 635
mice, inbred c57bl (635) 635
medicine, experimental (629) 629
disease models, animal (623) 623
activation (622) 622
signal transduction (620) 620
hepatocellular carcinoma (604) 604
laboratories (604) 604
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11852) 11852
Japanese (19) 19
Chinese (18) 18
German (10) 10
Spanish (4) 4
Portuguese (3) 3
French (1) 1
Russian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 22, pp. 2167 - 2179
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 22, pp. 2069 - 2077
Journal Article
Leukemia, ISSN 1476-5551, 2015, Volume 29, Issue 8, pp. 1754 - 1762
Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis (n = 23 272... 
ENGRAFTMENT | RISK-FACTORS | ONCOLOGY | BONE-MARROW-TRANSPLANTATION | BLOOD STEM-CELL | ACUTE MYELOGENOUS LEUKEMIA | UNRELATED DONORS | CLASS-I | SEVERE APLASTIC-ANEMIA | HEMATOLOGY | VERSUS-HOST-DISEASE | T-CELLS | Hematologic Neoplasms - therapy | Prognosis | Follow-Up Studies | Myeloablative Agonists - adverse effects | Hematologic Neoplasms - mortality | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Child, Preschool | Infant | Male | Transplantation, Homologous | Young Adult | Graft vs Host Disease - mortality | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Transplantation Conditioning - adverse effects | Primary Graft Dysfunction - etiology | Retrospective Studies | Hematologic Neoplasms - complications | Child | Graft vs Host Disease - etiology | Infant, Newborn | Primary Graft Dysfunction - drug therapy | Graft Survival | Survival Rate | Graft vs Host Disease - drug therapy | Primary Graft Dysfunction - mortality | Adolescent | Aged | Neoplasm Staging | Care and treatment | Transplantation | Blood diseases | Patient outcomes | Stem cells | Transplants & implants | Syngeneic grafts | Leukemia | Bone marrow transplantation | Grafting | Hematopoietic stem cells | Risk factors | Immunosuppressive agents | Prostaglandins | Granulocyte colony-stimulating factor | Cryopreservation | Failure analysis | Peripheral blood | Bone marrow | Colony-stimulating factor | Busulfan | Conditioning | Incompatibility | Risk reduction | Transplants | ABO system | Risk analysis | Myeloproliferative diseases | Hemopoiesis | Rejection | Cyclophosphamide | Immunosuppression | Grafts | Tacrolimus | Histocompatibility antigen HLA | Leukocytes (granulocytic) | leukemia | myelodysplastic syndrome | myeloproliferative disorders | Allogeneic hematopoietic cell transplantation | myeloablative | primary graft failure
Journal Article
Trends in Cardiovascular Medicine, ISSN 1050-1738, 2017, Volume 27, Issue 8, pp. 521 - 531
Abstract Congenital heart disease is a leading cause of death in the newborn period, and man-made grafts currently used for reconstruction are associated with multiple complications... 
Cardiovascular | Tissue engineering | Tissue-engineered vascular graft | Congenital cardiac disease | Bone marrow-derived mononuclear cells | Surgery | Fontan | CARDIAC & CARDIOVASCULAR SYSTEMS | STENOSIS | BONE-MARROW-CELLS | AUTOGRAFTS | PULMONARY-ARTERY | MODEL | CULTURE | TRANSPLANTATION | Heart Defects, Congenital - surgery | Humans | Child, Preschool | Bioprosthesis | Infant | Male | Blood Vessel Prosthesis | Prosthesis Design | Patient Selection | Tissue Scaffolds | Young Adult | Blood Vessel Prosthesis Implantation - adverse effects | Adult | Female | Child | Tissue Engineering - methods | Cell Transplantation - adverse effects | Blood Vessel Prosthesis Implantation - instrumentation | Risk Factors | Heart Defects, Congenital - pathology | Treatment Outcome | Animals | Graft Occlusion, Vascular - etiology | Adolescent | Graft Occlusion, Vascular - immunology | Heart Defects, Congenital - physiopathology | Graft Occlusion, Vascular - physiopathology | Cell Transplantation - methods | Vascular Patency | Medical colleges | Genetic disorders | Transplantation of organs, tissues, etc | Congenital heart disease | Heart diseases | Cardiovascular agents | Bone marrow | Transplantation | Prostheses | Pediatrics | Animal models | Congenital diseases | Immune response | Heart surgery | Syngeneic grafts | Pulmonary arteries | Heart transplantation | Mortality | Clinical trials | Stenosis | Cardiovascular disease | Patients | Coronary artery disease | Morbidity | Defects | Veins & arteries | tissue engineering | congenital cardiac disease | tissue-engineered vascular graft | bone marrow-derived mononuclear cells | surgery
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2012, Volume 367, Issue 16, pp. 1487 - 1496
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 13, pp. 1215 - 1226
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2018, Volume 128, Issue 1, pp. 219 - 232
Journal Article